Journal of Thrombosis and Thrombolysis

, Volume 17, Issue 2, pp 139–143 | Cite as

The Occasional Venous Thromboses Seen in Patients with Severe (Homozygous) FXII Deficiency are Probably Due to Associated Risk Factors: A Study of Prevalence in 21 Patients and Review of the Literature

  • A. Girolami
  • M.L. Randi
  • S. Gavasso
  • A.M. Lombardi
  • F. Spiezia


According to our personal experience and to the study of the literature, 11 cases of venous thrombosis have been described as sporadic reports in patients with severe (homozygous) factor XII (FXII) deficiencies. In every cases but 4, associated risk factors were found to be present (pregnancy, post-partum period, surgery, trauma, in dwelling catheter, AT deficiency, heterozygous factor V Leiden, Burger's disease). In some instances more then one condition was present. The four patients for whom no information is supplied, were cases gathered from old and logically incomplete files and therefore the existence of associated risk factors cannot be excluded.

The papers which investigated the presence of venous thrombosis in cohorts of patients with homoxygous FXII deficiency demonstrated the occurrence of venous thrombosis in 2 additional cases out of a total of 63 patients investigated. In these latter cases thrombosis occurred during pregnancy. This brings the total number of patients with FXII deficiency who showed a venous thrombosis to 13. Only a few of these patients were investigated for the presence of concomitant congenital prothrombotic conditions.

The conclusion of the study seem to suggest that the role played by FXII deficiency in the pathogenesis of venous thrombosis is minor, if any.

factor XII venous thrombosis hypercoagulability contact phase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ratnoff OD, Busse RJ, Shean RP. The demise of John Hageman. N Engl J Med 1968;279:760–761.Google Scholar
  2. 2.
    Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M. Factor XII (Hageman factor) deficiency: A risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction. Wien Med Wochenschr 1993;143:43–50.Google Scholar
  3. 3.
    Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: A report of 21 patients and a review of 50 previously reported cases. Medicine (Baltimore). 1983;62:248–255.Google Scholar
  4. 4.
    Girolami A, De Marco L, Dal Bo Zanon R, Patrassi G, Cappellato MG. Rare quantitative and qualitative abnormalities of coagulation. Clin Haematol. 1985;14:385–411.Google Scholar
  5. 5.
    Lammle B, Wuillemin WA, Huber I, et al. Thromboembolism and bleeding tendency in congenital factor XII deficiency-A study on 74 subjects from 14 Swiss families. Thromb Haemost 1991;65:117–121.Google Scholar
  6. 6.
    Colman RW. Contact Activation pathway: Inflammatory, fibrinolytic, anticoagulant, antiadhesive and antiangiogenic activities. In: Colman RW, Hirsh J, Marden VJ, Clowes AW, Teorge JM Eds. Thrombosis and Haemostasis. Philadelphia: Lippincott, Williams and Wilkins}, 4th ed., 2001.Google Scholar
  7. 7.
    Girolami A, Simioni P, Scarano L, Girolami B, Zerbinati P. Symptomatic combined homozygous factor XII deficiency and heterozygous factor V Leiden.JThromb Thrombolysis 2000;9:271–275.Google Scholar
  8. 8.
    Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. A "new" congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): Study of a large kindred. Br J Haematol 1970;19:179–192.Google Scholar
  9. 9.
    Girolami A, Patrassi G, De Marco L, Cappellato G. Lack of Factor XII antigen in Factor XII deficiency as determined by electroimmunoassy. Blut 1982;45:141–142.Google Scholar
  10. 10.
    Mannhalter C, Fischer M, Hopmaier P, Deutch E. Factor XII activity and antigen concentrations in patients suffering from recurrant thrombosis. Fibrinolysis 1987;1:259–263.Google Scholar
  11. 11.
    Hellstern P, Kohler M, Schmengler K, Doenecke P, Wenzel E. Arterial and venous thrombosis and normal response to streptokinase treatment in a young patient with severe Hageman factor deficiency. Acta Haematol 1983;69:123–126.Google Scholar
  12. 12.
    Bauman R, Straub PW. Congenital deficiency of Hagerman factors (clotting factor XII). Helv Med Acta 1968;34:313–316.Google Scholar
  13. 13.
    Maurin N, Schunkert H, Sieberth HG. Thrombophilia with a combination of antithrombin III and factor XII deficiency. Thromb Haemost 1988;60:127–128.Google Scholar
  14. 14.
    Okonkwo P, Post R, Sise H. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait. Thromb Diath Haemorrh 1970;23:423–431.Google Scholar
  15. 15.
    Samlaska CP, James WD, Simel DL. Superficial migratory thrombophlebitis and factor XII deficiency.JAmAcad Dermatol 1990;22:939–943.Google Scholar
  16. 16.
    von Kanel R, Wuillemin WA, Furlan M, Lammle B. Factor XII clotting activity and antigen levels in patients with thromboembolic disease. Blood Coagul Fibrinolysis 1992;3:555–561.Google Scholar
  17. 17.
    Koster T, Rosendaal FR, Briet E, Vandenbroucke JP. John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study. Br J Haematol 1994;87:422–424.Google Scholar
  18. 18.
    Girolami A, Maffei A, Brunetti A, Lazzarin M. Cholecystectomy in a patient with Hageman trait. Thromb Diath Haemorrh 1970;23:449–454.Google Scholar
  19. 19.
    Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004–1008.Google Scholar
  20. 20.
    Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64–67.Google Scholar
  21. 21.
    Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346}:1133–11Google Scholar
  22. 22.
    Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706–708.Google Scholar
  23. 23.
    Rodeghiero F, Castaman G, Ruggeri M, Tosetto A. Thrombosis in subjects with homozygous and heterozygous factor XII deficiency. Thromb Haemost 1992;67:590–591.Google Scholar
  24. 24.
    Aberg H, Nilsson IM. Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII. Acta Med Scand 1972;192:419–425.Google Scholar
  25. 25.
    Dyerberg J, Stoffersen E. Recurrent thrombosis in a patient with factor XII deficiency. Acta Haematol 1980;63:278–282.Google Scholar
  26. 26.
    Speicher L, Philipp W, Kunz FJ. Factor XII deficiency and central retinal vein occlusion. Lancet 1992;340:237.Google Scholar
  27. 27.
    Vergnes C, Lorient-Roudaut MF, Haissaguerre M, et al. Thrombophlebitis and pulmonary embolism in congenital The Occasional Venous Thromboses Seen in Patients 143 factor XII deficiency. Arch Mal Coeur Vaiss 1985;78:440–443.Google Scholar
  28. 28.
    Lao TT, Lewinsky RM, Ohlsson A, Cohen H. Factor XII de-ficiency and pregnancy. Obstet Gynecol 1991;78:491–493.Google Scholar
  29. 29.
    Colman RW, Bagdasarian A, Talamo RC, et al. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 1975;56:1650–1662.Google Scholar
  30. 30.
    Harris MG, Exner T, Rickard KA, Kronenberg H. Multiple cerebral thrombosis in Fletcher factor (prekallikrein) deficiency: A case report. Am J Hematol 1985;19:387–393.Google Scholar
  31. 31.
    Castaman G, Ruggeri M, Tosetto A, Missiaglia E, Rodeghiero F. Thrombosis in patients with heterozygous and homozygous factor XII deficiency is not explained by the associated presence of factor V Leiden. Thromb Haemost 1996;76:275.Google Scholar
  32. 32.
    Barthels M, Edel J, Liese B, Karges HE. Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome. Klin Wochenschr 1982;60:303–309.Google Scholar
  33. 33.
    Gordon EM, Donaldson VH, Saito H, Su E, Ratnoff OD. Reduced titers of Hageman factor (factor XII) in Orientals. Ann Intern Med 1981;95:697–700.Google Scholar
  34. 34.
    Schved JF, Gris JL, Neven S, Mares P, Sarlat C. Variation of factor XII level during pregnancy in a woman with Hageman factor deficiency. Thromb Haemostas 1988;60:526–527.Google Scholar
  35. 35.
    Sinakos Z, Suatan Y, Caen J, Bernard I. ItLe compartement des `elaquettes dans les maladies hemorragigues. Press Med 1967;75}:269–2Google Scholar
  36. 36.
    Winter M, Gallimore M, Jones DW. Should factor XII assays be included in thrombophilia screening? Lancet 1995;346:352Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • A. Girolami
    • 1
  • M.L. Randi
    • 1
  • S. Gavasso
    • 1
  • A.M. Lombardi
    • 1
  • F. Spiezia
    • 1
  1. 1.Department of Medical and Surgical Science, Second Chair of MedicineUniversity of Padua Medical SchoolPaduaItaly

Personalised recommendations